SBIR/STTR Research Award

Improved Renal Diagnoses using Gold Nanoparticle CT Imaging

Award identifier 2fb9d64f7d620d2cd76d6043021e2256adafd266d0d77bba397e25ab074e5d3aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$199,930

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOPROBES INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
JK7BK6JL14M6
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Over 10 million Americans suffer from chronic kidney disease and kidney cancer, resulting in 109,000 deaths a year and disability to many times that number. Better methods to study renal function and detect and accurate ly diagnose pathology are needed. Imaging is important to urology and nephrology, and improved functional kidney imaging could improve health care by enabling image guided diagnoses, procedures, therapies, and monitoring. Unfortunately, all of the x-ray co ntrast agents (which are based on iodine) are nephrotoxic, and a FDA warning has been issued discouraging use of gadolinium MRI imaging for persons with decreased renal function, thus limiting the important usefulness of CT and MRI. We have found that smal l gold nanoparticles produce excellent radiographic imaging of blood vessels and are rapidly filtered by the kidneys into the bladder thus producing exquisite imaging of the urinary system. Initial toxicity tests show them to be non-toxic at useful levels. These agents have a completely different chemistry from iodine and gadolinium agents and may be able to fill the void in noninvasive high resolution imaging of the urinary system. Preliminary tests have shown unsurpassed high resolution functional kidney imaging. In the work proposed, gold nanoparticles will be optimized and their safety evaluated in compromised kidneys compared to iodine agents in mice. Detection of acute tubular necrosis will be demonstrated using microCT. If this work is successful, the se novel contrast agents could lead to earlier and more accurate detection of renal pathology with concomitant improved treatments and outcomes for many patients. Relevance to Public Health: We have recently developed new agents to better image kidney func tion using nanotechnology. If this study is successful, these novel agents could lead to earlier and more accurate detection of kidney disorders resulting in improved treatments and outcomes for many patients.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

47 SBIR/STTR records share this UEI (1991–2025). Reported award amounts total $12,102,185. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.